Comparative study of filgrastim and lenograstim for peripheral blood stem cell mobilization in healthy donors

被引:0
作者
De la Rubia, J
Martnez, C
Solano, C
Brunet, S
Arrieta, R
Cascón, P
Alegre, A
Bargay, J
de Arriba, F
Cañizo, C
Zamora, C
Serrano, D
Verdeguer, A
Torrabadella, M
Daz, MA
Insunza, A
de la Serna, J
Espigado, I
Petit, J
Martnez, M
Benlloch, L
Sanz, MA
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
739
引用
收藏
页码:S219 / S219
页数:1
相关论文
共 50 条
[31]   Predictive markers for CD34+mobilization in healthy peripheral blood stem cell donors [J].
Koerper, S. ;
Hauber, D. ;
Fuerst, D. ;
Reinhardt, P. ;
Schauweker, P. ;
Mytilineos, J. ;
Schwarz, K. ;
Bunjes, A. ;
Wiesneth, M. ;
Schrezenmeier, H. .
Oncology Research and Treatment, 2015, 38 :35-36
[32]   G-CSF (filgrastim) for mobilization of stem cells in healthy donors [J].
Singhal, S ;
Powles, R ;
Cabral, S ;
Treleaven, J ;
Mehta, J .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :578-578
[33]   PERIPHERAL BLOOD STEM CELL COLLECTION IN HEALTHY DONORS [J].
Grubovic, R. ;
Georgievski, B. ;
Cevreska, L. ;
Dukovski, R. ;
Useini, S. ;
Pivkova, A. ;
Grubovic, M. .
VOX SANGUINIS, 2013, 105 :295-295
[34]   Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience [J].
Martino, Massimo ;
Dattola, Antonella ;
Fedele, Roberta ;
Pontari, Antonella ;
Moscato, Tiziana ;
Cuzzola, Maria ;
Martinello, Tiziana .
BLOOD, 2014, 124 (21)
[35]   The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey [J].
Sivgin, Serdar ;
Karakus, Esen ;
Kaynar, Leylagul ;
Kurnaz, Fatih ;
Pala, Cigdem ;
Keklik, Muzaffer ;
Zararsiz, Gokmen ;
Solmaz, Musa ;
Eser, Bulent ;
Cetin, Mustafa ;
Unal, Ali .
TRANSFUSION AND APHERESIS SCIENCE, 2013, 48 (03) :315-320
[36]   Factors affecting peripheral blood stem cells mobilization and collection in healthy donors [J].
Sancho, E. ;
Grifols, J. R. ;
Sancho, J. M. ;
Ester, A. ;
Morgades, M. ;
Junca, J. ;
Feliu, E. ;
Ribera, J-M .
TRANSFUSION, 2008, 48 (02) :127A-127A
[37]   Mobilization of healthy donors with G-CSF for allogenic transplant with peripheral blood stem cell (PBSC) [J].
Beléndez, C ;
Regidor, C ;
Sanjuán, I ;
Forés, R ;
Marcos, M ;
Fernández, P ;
Lago, M ;
Cabrera, R ;
Briz, M ;
Bañas, H ;
Peñalver, FJ ;
Barbolla, L ;
Fernández, MN .
BONE MARROW TRANSPLANTATION, 1998, 21 :S191-S191
[38]   Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience [J].
Marchesi, Francesco ;
Vacca, Michele ;
Gumenyuk, Svitlana ;
Pandolfi, Annino ;
Renzi, Daniela ;
Palombi, Francesca ;
Pisani, Francesco ;
Romano, Atelda ;
Spadea, Antonio ;
Ipsevich, Francesco ;
Santinelli, Susanna ;
De Rienzo, Mafalda ;
Papa, Elena ;
Canfora, Marco ;
Laurenzi, Lamberto ;
Foddai, Maria Laura ;
Pierelli, Luca ;
Mengarelli, Andrea .
LEUKEMIA & LYMPHOMA, 2016, 57 (02) :489-492
[39]   Filgrastim alone versus chemotherapy plus filgrastim for peripheral blood stem cell mobilization in multiple myeloma. [J].
Donato, ML ;
Chu, DT ;
Alexanian, R ;
Weber, DM ;
Korbling, MJ ;
Giralt, SA ;
Champlin, RE .
BLOOD, 2000, 96 (11) :182A-182A
[40]   Comparing the effectiveness of biosimilar filgrastim (Nivestim®) versus original filgrastim (Neupogen®) for stem cell mobilization in adult and pediatric healthy donors [J].
Muffarrej, Duaa ;
Hashem, Hasan ;
Tbakhi, Abdelghani ;
Najjar, Rula .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023,